The Cytokines 2024 and KAI 2024 Joint Meeting is just around the corner! Join us to learn from the brightest minds in Cytokine and Interferon research and gain the insights, techniques, and experiences you need to amplify your impact and build a global network. Invited speakers for Sunday and Monday, [READ MORE]
Katherine Fitzgerald Awarded the 2024 ICIS-Howard A. Young Distinguished Service Award [READ MORE]
Professor Karen Mossman has been selected as the recipient of the 2024 ICIS Honorary Lifetime Membership Award in recognition for her scientific accomplishments that center around basic virology, interferon responses and how to exploit this fundamental knowledge for clinical benefit as well as her long time commitment to the scientific community and members of the ICIS. [READ MORE]
On May 2, 2023, NIAMS Scientific Director of Intramural Research, Dr. John O’Shea, was elected to the U.S. National Academy of Sciences at the conclusion of the Academy’s 160th annual meeting. This designation – considered one of the highest honors that a scientist can achieve – recognizes distinguished and continuing achievements in original research. [READ MORE]
Christopher Garcia is the 2024 Passano Award winner in recognition for his research into the way molecules bind to one another and its implications for safer and more effective treatments. [READ MORE]
Each year, the International Cytokine & Interferon Society (ICIS) is thrilled to welcome approximately 200 new members, each bringing unique experiences and perspectives that enrich our community. Did you know that you can meet many of these new members in our regular Signals+ feature, New Member Mini-Bios? Reach out, welcome [READ MORE]
The ICIS continues to be managed as a virtual office, now with one office in San Francisco and one in Germany. Since the society is a US registered non-profit organization that has been incorporated in the US, and Co-Managing Director, Stephanie Flores is located in San Francisco, please use the [READ MORE]
Announcing the 2024 ICIS Young Investigator Awards [READ MORE]
When attending Cytokines / KAI 2024, the Local Organizing Committee wants to make sure you experience the best of Seoul. Here are the final two entries in our “Top 10 Must Visit” places in Seoul. Thanks to the Cytokines 2024 LOC member Jae Hun Shin, PhD, Yonsei University, Korea for [READ MORE]
Human Recombinant Interferon Gamma in the Treatment of Ventilator-acquired Pneumonia in ICU Patients (IGNORANT) ClinicalTrials.gov ID NCT05843786 Sponsor Hospices Civils de Lyon Information provided by Hospices Civils de Lyon (Responsible Party) Allogeneic Hematopoietic Cell Transplantation With Pegylated Interferon Alfa-2a for Primary and Secondary Myelofibrosis (ATIOM) ClinicalTrials.gov ID NCT05535764 Sponsor University [READ MORE]
International Cytokine & Interferon Society, Copyright 2024 Website Design by Rhema Association Management | Privacy Policy
